Evidence map›Paper›PMID 39648964›Full record

ReviewCPT: pharmacometrics & systems pharmacology2025

Advancing pharmacometrics in Africa-Transition from capacity development toward job creation.

Goonaseelan Colin Pillai, Samer Mouksassi, Innocent G Asiimwe, Craig R Rayner, Steven Kern, Phumla Sinxadi, Paolo Denti, Eric Decloedt, Catriona Waitt, Bernhards R Ogutu and 1 more

Abstract readReview
In one paragraph

Review in CPT: pharmacometrics & systems pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Catalyzing change in MID3 through globalization, education, and innovation.Journal of pharmacokinetics and pharmacodynamics · 2025
    Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Goonaseelan Colin PillaiDivision of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.ORCID 0000-0002-5658-3837
Samer MouksassiPharmacometrics Africa NPC, Cape Town, South Africa.ORCID 0000-0002-7152-6654
Innocent G AsiimwePharmacometrics Africa NPC, Cape Town, South Africa.ORCID 0000-0002-1196-1822
Craig R RaynerModerna, Melbourne, Victoria, Australia.
Steven KernGlobal Health Labs, Seattle, Washington, USA.ORCID 0000-0002-2849-0836
Phumla SinxadiDivision of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.ORCID 0000-0002-1312-3523
Paolo DentiDivision of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.ORCID 0000-0001-7494-079X
Eric DecloedtDivision of Clinical Pharmacology, Department of Medicine, Stellenbosch University, Cape Town, South Africa.ORCID 0000-0003-1815-5150
Catriona WaittPharmacometrics Africa NPC, Cape Town, South Africa.ORCID 0000-0003-0134-5855
Bernhards R OgutuCentre for Research in Therapeutic Sciences, Strathmore University, Nairobi, Kenya.ORCID 0000-0002-0992-5654
Rik de GreefCertara Inc, Radnor, Pennsylvania, USA.ORCID 0009-0009-0192-775X

Funding

Urine tenofovir point-of-care test to identify patients in need of ART adherence supportR01AI152119 · NIAID · STELLENBOSCH UNIVERSITY · PI GANDHI, MONICA, ORRELL, CATHERINE · 2020 to 2024
$1.7M
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and strokeR21TW012384 · FIC · STELLENBOSCH UNIVERSITY · PI DECLOEDT, ERIC HERMANN, ORRELL, CATHERINE · 2023 to 2024
$304k
Study of Metformin to reduce Cerebrovascular Dysfunction in South African patients with HIV and Metabolic Syndrome: A Phase II Pilot Trial. SMARTR21TW012185 · FIC · STELLENBOSCH UNIVERSITY · PI DECLOEDT, ERIC HERMANN, SCHIFITTO, GIOVANNI · 2021 to 2022
$302k
Certara, Inc.European and Developing Countries Trials Partnership 101103201FIC NIH HHS R21 TW012185FIC NIH HHS R21TW012185FIC NIH HHS R21 TW012384FIC NIH HHS R21TW012384Gates FoundationNIAID NIH HHS R01 AI152119NIAID NIH HHS R01AI152119-01Pharmacometrics Africa NPCWellcome TrustWellcome Trust Clinical Research Career Development 222075_Z_20_Z
6 · The paper itself

Abstract

Trained pharmacometricians remain scarce in Africa due to limited training opportunities, lack of a pharmaceutical product development ecosystem, and emigration to high-income countries. The Applied Pharmacometrics Training (APT) fellowship program was established to address these gaps and specifically foster job creation for talent retention. We review the APT program's progress over 3 years and encourage collaboration to enhance local clinical data analysis in Africa. Initiated in 2021 by Pharmacometrics Africa, a non-profit educational entity, with support from partners including the Bill & Melinda Gates Foundation and Certara, the APT program targets African doctoral-level scientists and clinicians. This 6-month program is jointly managed by partners, with Pharmacometrics Africa handling logistics and sponsor liaison. Job creation initiatives include inviting fellows to join consulting teams or local research centers. Over the 3 year reporting period, 177 applications were received, with 27 individuals (41% female, median age 35 years) from nine African countries selected into and completing the full program. The fellows worked on 13 data analysis projects, with six so far being presented at international conferences and/or submitted for publication in peer-reviewed journals. Nine fellows have joined consulting teams or research centers working from offices in Africa. Currently, in the 3rd year, the APT program has demonstrated success in skills development, job creation, and fostering a critical mass of African pharmacometricians. Collaboration is essential for the sustainable advancement of model-informed drug development in Africa.

Indexed as

Capacity BuildingDrug DevelopmentAdultAfricaFellowships and ScholarshipsFemaleHumansMale

Identifiers

PMID39648964
PMCPMC11919256

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.